Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Agency Bill Department Of Health topic
No spam. Unsubscribe anytime.
Senate advances Department of Health agency bill while officials report $40 million in federal COVID funding terminated
Summary
Senate Health Committee moved House Bill 1457, the Department of Health agency bill, as amended and recommitted it to appropriations. During testimony Department staff said federal COVID grants previously extended were terminated immediately, estimating a roughly $40 million impact and promising further details.
Get email alerts on the Agency Bill Department Of Health topic
No spam. Unsubscribe anytime.
The Senate Health Committee approved amendments to the Department of Health agency bill (House Bill 1457) and voted to recommit the measure to appropriations.
Bill author Rep. Brad Barrett described the agency bill as technical and having multiple stakeholder‑vetted provisions, including involuntary transfer authority for long‑term care facilities, updates to WIC program definitions and updates to background-check rules for certain long‑term-care hires.
During testimony Rachel Swartwood, legislative and external affairs director for the Indiana Department of Health, told the committee the department had received an immediate federal notification that extended COVID grants were terminated. She said staff were "working with our team to evaluate what's going on" and estimated the program-level impact in the ballpark of $40,000,000, adding the department's priority was to ensure no direct services to Hoosiers were disrupted.
Committee action
The committee adopted technical and stakeholder amendments (hospital design/fees; maternal mortality review committee; state health laboratory fees; cleanup of duplicated criminal penalty language) and the amended bill passed the committee as recommitted to appropriations. The roll call showed unanimous support (12-0) as amended with recommitment.
Why it matters
The agency bill contains several technical but operationally important changes that affect regulatory processes (for example, clarifying stillbirth reporting deadlines and enabling the Department of Health to approve third-party epinephrine training programs). The sudden federal grant termination announcement introduces an urgent budgetary question; the department estimated the grants' termination could approach $40 million and said it was still evaluating the full impact and notifying staff and stakeholders.
Relevant excerpts
"Yesterday, we were notified that our federal COVID grants that were previously extended, have been terminated," Rachel Swartwood said. "We are working with our team to evaluate what's going on communicating with our staff and our goal is to ensure that no direct services to Hoosiers are disrupted and we'll keep you updated as we find out more information."
Other details in the bill
- Stillbirth reporting: the bill clarifies who must initiate stillbirth certificates and shortens administrative timelines; the department told the committee that the average time for stillbirth certificate submission was about 26.9 days but state law expects the filing within five days.
- Epinephrine standing order: the bill would streamline approval of third-party organizations offering epinephrine (EpiPen) training and standing orders, intended to expand community access to emergency epinephrine.
Next steps
The committee sent the amended bill to appropriations for review and budgeting. Department staff said they would return with details on the federal funding termination and follow up on any appropriation or contingency planning.
